Preparation Sessions
EMBARK Psychedelic Therapy for Depression April 23, 2024 DOI: 10.1093/9780197762622.003.0006 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Duration | Three 90-minute sessions |
| Key points | Proposes that a preparation phase of three 90-minute nondrug sessions, structured around the six EMBARK domains, lays groundwork for potential benefits in psychedelic therapy for depression. |
Abstract
AbstractChapter 5 outlines a preparation phase consisting of three 90-minute nondrug sessions. Preparation lays the groundwork for potential benefits across the six EMBARK domains. The therapist’s aims in this phase include building trust, understanding the participant’s experience of depression, identifying participant intentions, and providing psychoeducation about psychedelic therapy. The chapter provides concrete instructions for the preparation sessions in each of the six EMBARK clinical domains. For example, the therapist: (E) aims to create an environment that encourages profound spiritual experiences; (M) teaches techniques for compassionate internal focus and self-soothing; (B) fosters an appreciation for somatic practices; (A) encourages the participant to openly receive their emotions and beliefs; (R) strives to cultivate a therapeutic relationship characterized by safety, acceptance, and empowerment while considering the participant’s trauma history and cultural context; and (K) codevelops strategies to promote continuity of therapeutic gains. Three session agendas are provided.
Citations in the library
Cites 217
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
and 212 more in the library